Get the Stockscreener App
3.565
2.89%
-0.07
Alector Inc stock is traded at $3.565, with a volume of 109.35K.
It is down -2.89% in the last 24 hours and down -23.43% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$3.635
Open:
$3.65
24h Volume:
109.35K
Relative Volume:
0.20
Market Cap:
$367.25M
Revenue:
$97.06M
Net Income/Loss:
$-130.39M
P/E Ratio:
-2.0727
EPS:
-1.72
Net Cash Flow:
$-186.54M
1W Performance:
-28.11%
1M Performance:
-23.43%
6M Performance:
-34.51%
1Y Performance:
-26.15%
1-Day Range:
$3.49
$3.675
1-Week Range:
$3.49
$5.01
52-Week Range:
$3.49
$8.90
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ALEC | 3.565 | 367.25M | 97.06M | -130.39M | -186.54M | -1.72 |
| VRTX | 447.11 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 740.93 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.30 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 250.31 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.89 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Goldman Sachs maintains sell on Alector, target $4 amid Alzheimer's study - Investing.com India
Alector stock hits 52-week low at $4.05 amid market challenges - Investing.com Canada
Alector, Inc. (NASDAQ:ALEC) Shares Sold by US Bancorp DE - Defense World
Alector (ALEC) Reports Q3 Loss, Misses Revenue Estimates - MSN
Alector, Inc. announced that it expects to receive $50 million in funding from Hercules Capital, Inc., and other investors - Marketscreener.com
Alector secures $50 million credit facility from Hercules Capital - Investing.com India
ALECAlector, Inc. Latest Stock News & Market Updates - StockTitan
Alector secures $50 million credit facility from Hercules Capital By Investing.com - Investing.com UK
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital - GlobeNewswire
Alector, Inc. Secures Flexible Credit Facility for Up to $50 Million from Hercules Capital, Inc - Marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Position Reduced by Baillie Gifford & Co. - MarketBeat
Alector (ALEC) Shares Plunge Amid Industry Volatility - GuruFocus.com
Creative Planning Increases Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
FY2024 Earnings Forecast for Alector Issued By HC Wainwright - Defense World
William Blair Has Strong Outlook for Alector FY2024 Earnings - Defense World
Alector (NASDAQ:ALEC) Earns Buy Rating from HC Wainwright - Defense World
FY2024 Earnings Estimate for Alector Issued By HC Wainwright - MarketBeat
FY2024 Earnings Estimate for Alector Issued By William Blair - MarketBeat
Alector (NASDAQ:ALEC) Announces Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Head to Head Review: Alector (NASDAQ:ALEC) vs. BioAtla (NASDAQ:BCAB) - Defense World
Alector Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Morgan Stanley's Strategic Reduction in Alector Inc Shares - GuruFocus.com
Alector (NASDAQ:ALEC) Earns "Buy" Rating from HC Wainwright - MarketBeat
Alector: Q3 Earnings Snapshot - The Bakersfield Californian
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Alector earnings beat by $0.10, revenue fell short of estimates - Investing.com Canada
Alector (NASDAQ:ALEC) Trading 7% HigherTime to Buy? - MarketBeat
Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Alector, Inc. (NASDAQ:ALEC) Short Interest Update - MarketBeat
SG Americas Securities LLC Sells 33,430 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc.'s (NASDAQ:ALEC) Business And Shares Still Trailing The Industry - Simply Wall St
Alector, Inc. (NASDAQ:ALEC) Short Interest Up 19.9% in September - MarketBeat
Cubist Systematic Strategies LLC Purchases 38,947 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Marshall Wace LLP Lowers Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Was anything negative for Alector Inc (ALEC) stock last session? - US Post News
Dimensional Fund Advisors LP Has $3.07 Million Stock Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Alector Inc [ALEC] Chief Financial Officer makes an insider sale of 7,297 shares worth 35,620. - Knox Daily
The Future of Alector Inc: Analyzing ALEC - The InvestChronicle
Alector (ALEC) Stock Surges Over 5% Amid Positive Institutional Ratings - GuruFocus.com
ProShare Advisors LLC Sells 4,070 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Insider’s View: Deciphering Alector Inc (ALEC)’s Financial Health Through Ratios - The Dwinnex
Frontotemporal Dementia Pipeline 2024: Clinical Trials - openPR
Frontotemporal Dementia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics, Passage Bio - Barchart
Recent Insider Activity Suggests Potential Gains for Alector Inc (ALEC) - Knox Daily
Cubist Systematic Strategies LLC Has $419,000 Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by American Century Companies Inc. - Defense World
Alector Inc (ALEC) Stock: A Year of Declines and Increases - The InvestChronicle
Check out these key findings about Alector Inc (ALEC) - SETE News
View On Upcoming Q4 Biotech Catalysts: Part 1 (ALEC, ARVN, AMLX) (NASDAQ:ALEC) - Seeking Alpha
Examining Alector Inc (ALEC) stock is warranted - US Post News
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):